Efficacy of Nilotinib in Adult Patients With Gastrointestinal Stromal Tumors Resistant to Imatinib and Sunitinib.
Clinical trial NCT01289028 · COMPLETED
Trial details
- NCT number
- NCT01289028
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-11-01
- Primary completion
- 2014-07-01
- Enrollment
- 125
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.